As shown in Figure 1(d), the expression level of B4GALNT1 in the tumor tissues of BRCA, CHOL, HNSC, KIRC, LIHC, LUAD, LUSC (P < 0.001), ESCA, PCPG (P < 0.01), KICH, and STAD (P < 0.05) is higher than that in the corresponding normal tissues, while B4GALNT1 was expressed lower in COAD, PRAD (P < 0.001), GBM, KIRP, THCA, UCEC (P < 0.01), and READ (P < 0.05) compared with normal tissues. Here, B4GALNT1 is linked to prostate adenocarcinoma.